메뉴 건너뛰기




Volumn 9, Issue 2, 2009, Pages 419-423

Erratum: Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: Over the 10-year mark (American Journal of Transplantation (2009) 9 (419-423) DOI:10.1111/j.1600-6143.2008.02481.x);Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: Over the 10-year mark

Author keywords

Immunosuppression; Islet transplantation; Long term function; T regs; Type 1 diabetes

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INSULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; THYMOCYTE ANTIBODY;

EID: 58849141234     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03856.x     Document Type: Erratum
Times cited : (77)

References (17)
  • 1
    • 0034721255 scopus 로고    scopus 로고
    • Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen
    • Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000 343 : 230 238.
    • (2000) N Engl J Med , vol.343 , pp. 230-238
    • Shapiro, A.M.1    Lakey, J.R.2    Ryan, E.A.3
  • 3
    • 21344462346 scopus 로고    scopus 로고
    • Five-year follow-up after clinical islet transplantation
    • Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005 54 : 2060 2069.
    • (2005) Diabetes , vol.54 , pp. 2060-2069
    • Ryan, E.A.1    Paty, B.W.2    Senior, P.A.3
  • 4
    • 19544383042 scopus 로고    scopus 로고
    • Strategic opportunities in clinical islet transplantation
    • Shapiro AMJ, Lakey JRT, Paty BW et al. Strategic opportunities in clinical islet transplantation. Transplantation 2005 79 : 1304 1307.
    • (2005) Transplantation , vol.79 , pp. 1304-1307
    • Shapiro, A.M.J.1    Lakey, J.R.T.2    Paty, B.W.3
  • 5
    • 0035085643 scopus 로고    scopus 로고
    • Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol
    • Ryan EA, Lakey JRT, Rajotte RV et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes 2001 50 : 710 719.
    • (2001) Diabetes , vol.50 , pp. 710-719
    • Ryan, E.A.1    Lakey, J.R.T.2    Rajotte, R.V.3
  • 6
    • 12144252016 scopus 로고    scopus 로고
    • Beta-cell function following human islet transplantation for type 1 diabetes
    • Rickels MR, Schutta MH, Markmann JF et al. Beta-cell function following human islet transplantation for type 1 diabetes. Diabetes 2005 54 : 100 106.
    • (2005) Diabetes , vol.54 , pp. 100-106
    • Rickels, M.R.1    Schutta, M.H.2    Markmann, J.F.3
  • 8
    • 19944434343 scopus 로고    scopus 로고
    • Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation
    • Bucher P, Mathe Z, Morel P et al. Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation. Transplantation 2005 79 : 91 97.
    • (2005) Transplantation , vol.79 , pp. 91-97
    • Bucher, P.1    Mathe, Z.2    Morel, P.3
  • 9
    • 33751503142 scopus 로고    scopus 로고
    • Monitoring of the islet graft
    • Berney T, Toso C. Monitoring of the islet graft. Diabetes Metab 2006 32 : 502 512.
    • (2006) Diabetes Metab , vol.32 , pp. 502-512
    • Berney, T.1    Toso, C.2
  • 10
    • 0012431804 scopus 로고    scopus 로고
    • Report of the expert committee on the diagnosis and classification of diabetes mellitus
    • Expert Committee on the Diagnosis and Classification of Diabetes Mellitus.
    • Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003 26 (Suppl 1 S5 S20.
    • (2003) Diabetes Care , vol.26 , Issue.1
  • 11
    • 0023927902 scopus 로고
    • Frequency analysis of cytotoxic T lymphocyte precursors-possible relevance to HLA-matched unrelated donor bone marrow transplantation
    • Kaminski E, Sharrock C, Hows J et al. Frequency analysis of cytotoxic T lymphocyte precursors-possible relevance to HLA-matched unrelated donor bone marrow transplantation. Bone Marrow Transplant 1988 3 : 149 155.
    • (1988) Bone Marrow Transplant , vol.3 , pp. 149-155
    • Kaminski, E.1    Sharrock, C.2    Hows, J.3
  • 12
    • 22144445286 scopus 로고    scopus 로고
    • Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetic patients
    • van Kampen CA, van de Linde P, Duinkerken G et al. Alloreactivity against repeated HLA mismatches of sequential islet grafts transplanted in non-uremic type 1 diabetic patients. Transplantation 2005 81 : 118 126.
    • (2005) Transplantation , vol.81 , pp. 118-126
    • Van Kampen, C.A.1    Van De Linde, P.2    Duinkerken, G.3
  • 13
    • 13844265752 scopus 로고    scopus 로고
    • Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes
    • Hering BJ, Kandaswamy R, Ansite JD et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005 293 : 830 835.
    • (2005) JAMA , vol.293 , pp. 830-835
    • Hering, B.J.1    Kandaswamy, R.2    Ansite, J.D.3
  • 14
    • 0041842617 scopus 로고    scopus 로고
    • Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplantation
    • Fiorina P, Folli F, Zerbini G et al. Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplantation. J Am Soc Nephrol 2003 14 : 2150 2158.
    • (2003) J Am Soc Nephrol , vol.14 , pp. 2150-2158
    • Fiorina, P.1    Folli, F.2    Zerbini, G.3
  • 15
    • 0041666293 scopus 로고    scopus 로고
    • Beta-cell function and the development of diabetes-realted complications in the diabetes control and complications trial
    • Steffes MW, Sibley S, Jackson M, Thomas W. Beta-cell function and the development of diabetes-realted complications in the diabetes control and complications trial. Diabetes Care 2003 26 : 832 836.
    • (2003) Diabetes Care , vol.26 , pp. 832-836
    • Steffes, M.W.1    Sibley, S.2    Jackson, M.3    Thomas, W.4
  • 17
    • 37549045308 scopus 로고    scopus 로고
    • Rapamycin impairs in vivo proliferation of islet beta-cells
    • Zahr E, Molano RD, Pileggi A et al. Rapamycin impairs in vivo proliferation of islet beta-cells. Transplantation 2007 84 : 1576 1583.
    • (2007) Transplantation , vol.84 , pp. 1576-1583
    • Zahr, E.1    Molano, R.D.2    Pileggi, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.